bpc 157 human clinical trial pain BPC-157: The Secret Weapon for Injury Repair & Gut Health | Desert Mobile Medical Peptide BPC-157 - Does It

Glucagon-like peptide-1 receptor agonist prevented the progression of hepatocellular carcinoma in a mouse model of nonalcoholic Steatohepatitis

It works on three hormone receptors at once (GLP-1, GIP, and glucagon), which is why some people call it a triple agonist or Triple G. Its half-life sits around 6 days, so a single weekly shot is enough to keep blood levels steady

[DOI] [PubMed] [Google Scholar] Pevec D, Novinscak T, Brcic L, et al

POTENT ANTI-INFLAMMATORY EFFECTS

Because BPC-157 lacks robust human safety data across the proposed routes of administration, the FDA states it does not have enough information to know whether compounded BPC-157 would cause harm in humans

A more recent study 44 based on the S-pK a dataset, which collected data from previous publications and other open-access pK a databases, also proposed that the XGB model (MAE = 0.57 for acids, 0.55 for bases) outperformed SVM, RF, and NN models